drugset / Trial / NCT03701880
Early Use of Ivabradine in Heart Failure
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim of the work is to Evaluate the efficacy, quality of life and safety of early addition of ivabradine to B-blocker in reduced EF heart failure patients after acute decompensation compared to the standard treatment.
Timeline
- Start
- 2018-09-16
- Primary completion
- 2019-12-23
- Completion
- 2019-12-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ivabradine | Small molecule | 7.5 mg | — |
| Background | Bisoprolol | Other / unclassified | 10 mg | — |